Consolidation shows no signs of slowing

Consolidation shows no signs of slowing


19 February 2016 - Deborah Wilkes


The OTC Deal Trends 2016 BRIEFING from OTCToolbox provides a comprehensive guide to the main acquisitions and key trends in the global OTC/consumer healthcare market.

Buy and download OTC Deal Trends 2016 today to read:

  • 10 key OTC deal trends
  • Executive summary
  • In-depth review of deals and trends
  • Quick guide to purchase prices for OTC deals
  • Trends in vitamins, minerals and supplements
  • Trends in skincare
  • Trends in emerging markets

Mega OTC deals continued to dominate the headlines in 2015 and early 2016, with GlaxoSmithKline completing its consumer healthcare joint venture with Novartis, generics giant Mylan failing in its bid to acquire Perrigo and then striking a deal for Meda, and Sanofi and Boehringer Ingelheim unveiling exclusive asset-swap talks. There was also plenty of speculation about which leading OTC players might be divested in future.

Meanwhile, VMS and skincare assets changed hands at a brisk pace, private-equity firms seemed to pop up everywhere, and there were interesting developments in emerging markets.

The Briefing, which has more than 115 pages, is written by OTC industry expert Deborah Wilkes, who is the Editor & Publisher of OTCToolbox.

It is available to purchase and download immediately from the OTCToolbox website as a PDF. Make sure your team is well informed through a Multiple User Licence or a Global Licence for the Briefing. The Briefing is available free to people who have a current paid-for Annual Subscription to the OTCToolbox website.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Briefings

Share this page: